ABSTRACT
INTRODUCTION
The development of new methods of anesthesia and postoperative care protocols, such as fast-track recovery (FTRC), has contributed to signifi cant reductions in postoperative mechanical ventilation time, intensive care unit (ICU) stay, and length of hospital stay following cardiac surgical procedures [Higgins 1992 [Higgins , 1995 Engelman 1994; Karski 1995; Marquez 1995; Cheng 1998; Alhan 2003; Celkan 2005] . This method generally targets the patient for extubation within 6 to 8 hours of the completion of the cardiac procedure, an ICU length of stay of <24 hours, and a total hospital length of stay of 4 to 6 days. It has been used successfully for both low-and high-risk patients [Konstantakos 2000; Capdeville 2001; Lazar 2001] .
The FTRC steps of primary focus include an earlier extubation and a shorter ICU stay. The ICU readmission rate, which is one of the most accurate quality indicators, has usually been given less concern [Bardell 2003; Toraman 2005] . Thus, an appropriate analysis related to the heterogeneity of the patient groups undergoing different types of cardiac surgery has not yet been undertaken. In the present study, we investigated ICU readmission and outcome data according to the type of surgical procedure.
METHODS
Between 1999 and 2008, we prospectively enrolled 4270 consecutive patients who underwent isolated coronary artery bypass grafting (CABG) (CABG group, n = 3754), isolated valve surgery (valve group, n = 353), or combined CABG and valve surgery (CABG + valve group, n = 163) in the study. None of the patients were excluded for any reason. A single surgical and anesthesia team performed all of the operations, and the same physician provided postoperative care to all of the patients.
Anesthesia and Operative Technique
On the night before the operation, all patients received 0.5 mg alprazolam by mouth. Midazolam (125 μg/kg) was administered intramuscularly 30 minutes before the operation. MgSO 4 was infused for prophylaxis of atrial fi brillation 1 day before the operation and 4 more days postoperatively. A 16-gauge intravenous cannula was inserted in all patients in the operating room. The patients' NaCl drip was 100 mL/ hour. Anesthesia induction consisted of 50 μg/kg midazolam, 0.15 mg/kg pancuronium, and 25 to 35 μg/kg fentanyl.
After endotracheal intubation, 50% O 2 , 50% N 2 O, and 3% to 4% desfl urane were used for all hemodynamically stable patients. Desfl urane and N 2 O were discontinued at times of hemodynamic instability. Maintenance anesthesia and muscle relaxation were accomplished with 8 to 10 μg/kg fentanyl per hour and with midazolam and vecuronium at 80 μg/kg per hour. Furosemide (0.5 mg/kg) was administered routinely. The priming solution for cardiopulmonary bypass (CPB) included 900 mL Ringer's lactate solution, 150 mL 20% mannitol, and 60 mL sodium bicarbonate (8.4%). During CPB, the hematocrit, mean arterial pressure, and pump fl ow were kept between 20% and 30%, 50 and 80 mm Hg, and 2.2 and 2.5 L/m 2 , respectively. The adequacy of tissue perfusion was assessed by monitoring the arteriovenous partial carbon dioxide difference (Pv-aCO 2 ), the lactate level, the urine output, and the base defi cit. Moderate hypothermia was Th e Heart Surgery Forum #2010-1009
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used during CPB, and the midazolam and vecuronium dosage was decreased to 60 μg/kg per hour when the body temperature reached 32°C. Myocardial viability was preserved with antegrade cold hyperkalemic crystalloid cardioplegia (Plegisol®; Abbott Laboratories, Abbott Park, IL, USA), except in patients with a left ventricular ejection fraction <0.25. In these patients, antegrade and retrograde blood cardioplegia associated with terminal warm blood cardioplegia was used. During rewarming, the midazolam and vecuronium dosage was increased back to 80 μg/kg per hour. After the termination of CPB, the midazolam and vecuronium dosage was decreased to 50 μg/kg per hour and discontinued at skin closure.
Postoperative Clinical Management
On arrival in the ICU, patients were placed on mechanical ventilation. The ventilator mode was switched to synchronized intermittent mandatory ventilation plus pressure support, and ventilator settings were adjusted as follows: respiratory rate, 12/min; tidal volume, 8 to 10 mL/kg; fraction of inspired oxygen (FIO 2 ), 0.6; positive end-expiratory pressure, 0 to 5 mm Hg; pressure support, 10 mm Hg; and trigger sensitivity, -2 cm H 2 O. All patients were warmed by forced-air warming until the rectal temperature reached 37°C. The basic fl uid substitution during the fi rst 20 postoperative hours was 40 mL/kg per day. Six hundred to 800 mL of this solution was the autologous blood derived from the CPB circuit, and the rest was balanced crystalloid solution. Intravenous meperidine (0.4 mg/kg, to a total dose of 50 mg over 6 hours) was used to treat shivering. All patients were evaluated for extubation every half hour. As soon as spontaneous breathing resumed, the respiratory rate was gradually decreased to 4/min, and pressure support was reduced to 4 mm Hg. If there were no contraindications for the use of beta-blockers, metoprolol was used intravenously to control hypertension. All hemodynamically stable patients who had no excessive chest tube drainage, a PaCO 2 value <48 mm Hg, a pH >7.30, and a PaO 2 /FIO 2 ratio >250 were extubated. After the patient was extubated, 40% to 50% oxygen was administered by face mask. Oxygen saturation of hemoglobin and the respiratory rate were monitored continuously. Arterial blood gas measurements were obtained at 30, 60, and 120 minutes after extubation. Repeated intramuscular doses of diclofenac sodium (1.25 mg/kg) were used for postoperative analgesia. Patients >70 years of age with a hemoglobin value <8 g/dL and patients ≤70 years of age with a hemoglobin value <7 g/dL received packed red blood cells. Patients with a tendency to bleed were treated by transfusion with fresh frozen plasma. Inotropes were used only when hemodynamic stabilization could not be achieved by fl uid administration or when there was other evidence of impaired contractility. In the case of an insuffi cient response to inotropes, intra-aortic balloon counterpulsation was initiated. All patients were evaluated for discharge from the ICU on the morning after the operation, regardless of their operation type and time. Patients were not transferred from the ICU if they were considered at clinically high risk, with signs of inadequate tissue perfusion (lactate >4 mmol/L, mixed venous oxygen saturation <50%, urine output <0.5 mL/kg per hour, cardiac index <2 L/min per square meter), requiring inotropes other than low-dose dopamine (3 μg/kg per minute), signifi cant hemodynamic instability, requiring the use of an intra-aortic balloon pump, or needing circulatory support.
We aimed to discharge all patients on the fi fth postoperative day. The decision to discharge was based on a satisfactory routine checkup on day 4, which consisted of a clinical examination; a complete blood cell count, measurements of blood urea nitrogen, creatinine, and electrolyte levels; an electrocardiogram; and a chest radiograph. If the patient was medically unfi t on day 5, the hospitalization was prolonged, and further investigations were performed, depending on the patient's clinical status. Because the objective of our FTRC program was to extubate the patients within 6 hours of the completion of the cardiac procedure, to discharge from the ICU within 24 hours, and to discharge from the hospital on fi fth postoperative day, these time points were taken as references in this study.
Data Source and Defi nitions
Our clinical database was used for outcomes analysis. It is a prospectively collected record containing relevant patient demographic data, comorbidities, intraoperative variables, and postoperative outcomes, including postoperative drainage, ventilation time, length of ICU stay, length of hospital stay, transfusion rate, new-onset postoperative renal failure, postoperative stroke, rate of readmission to the ICU, rate of readmission to the hospital, and mortality. Hospital mortality included all deaths within 30 days of the operation, irrespective of where the death occurred, and all deaths in the hospital after 30 days among patients who had not been discharged after their operation. Postoperative blood loss was defi ned as the total volume of the chest tube drainage. Renal complications included acute renal failure, which was defi ned as the requirement of hemodialysis or an elevated creatinine level (>200 μmol/L). Stroke included postoperative permanent and temporary neurologic dysfunction.
Statistical Analysis
Data are reported as a percentage or as the mean ± SD. Univariate comparisons were evaluated by means of the χ 2 test or the Fisher exact test for categorical variables and by Student t tests for continuous variables. Any factor with a P value <0.1 in the univariate analysis was entered into the multiple logistic regression analysis. Statistical analysis was performed with SPSS statistical software (version 11.0; SPSS, Chicago, IL, USA). Variables were considered signifi cant at P values <.05.
RESULTS
Demographic and perioperative data and demographics for the entire group are presented in Table 1 . Ninetyeight patients (2.2%) were readmitted to the ICU. Of these patients, 73 were in the CABG group (1.9% of this group), 16 were in the valve group (4.5%), and 9 were in the CABG + valve group (5.5%). The main reason for ICU readmission in all groups was respiratory distress (Table 2 ).
In the CABG group, the univariate analysis defi ned the following risk factors for ICU readmission: congestive heart failure (P = .048), hypertension (P = .08), hypothyroidism (P = .02), chronic obstructive lung disease (P = .04), peripheral arterial disease (P = .03), left main disease (P = .015), preoperative intravenous nitrates (P = .01), operative priority (P = .001), New York Heart Association (NYHA) class III to IV (P = .01), age >65 years (P = .001), a EuroSCORE >5 (P = .001), cross-clamp time >40 minutes (P = .005), pump time >60 minutes (P = .002), ICU stay >24 hours (P = .001), postoperative drainage >500 mL (P <.001), and transfusion of red blood cells (P = .001). The univariate risk factors for readmission to the ICU in the valve group were congestive heart failure (P = .002), beta-blocker use (P = .008), preoperative intravenous nitrates (P = .01), diuretic drug use (P = .03), a EuroSCORE >5 (P = .09), and transfusion of red blood cells (P = .03). In the CABG + valve group, female sex (P = .02), congestive heart failure (P = .004), preoperative heparin use (P = .006), NYHA class III to IV (P = .03), and perioperative transfusion of red blood cells (P = .04) were the univariate risk factors for ICU readmission (Table 3) . A multivariate analysis (Table 4) showed that the independent risk factors for ICU readmission in the CABG group were an age >65 years (odds ratio [OR] , 2.9; 95% confi dence interval [CI], 1.5-5.4; P = .001), peripheral arterial disease (OR, 2.7; 95% CI, 1.2-6.1; P = .016), and drainage >500 mL (OR, 2.5; 95% CI, 1.2-5.1; P = .009). Independent risk factors for the valve group included only preoperative congestive heart failure (OR, 3.9; 95% CI, 1.3-11.7; P = .01). No independent risk factor was defi ned for the CABG + valve group. The mortality rates were signifi cantly higher for the readmitted patients in all groups (Table 5) . Red blood cell transfusion 55.5 88.9 .04 *CABG indicates coronary artery bypass grafting; CHF, congestive heart failure; IV, intravenous; NYHA, New York Heart Association; CPB, cardiopulmonary bypass.
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DISCUSSION
The overall ICU readmission rate in the study was 2.2% after FTRC. The rate was higher in the valve group (4.5%) and in the CABG + valve group (5.5%) than in the CABG group (1.9%). The ICU readmission rate is accepted as a quality indicator, and the risk of such complications as stroke, reoperation, prolonged mechanical ventilation, prolonged hospitalization, and mortality have been found to be higher in readmitted patients [Bardell 2003 ]. The literature has reported this rate to be in the range of 3.6% to 5.5% after traditional cardiac surgical care [Cohn 1999; Bardell 2003] and is reportedly lower for FTRC [Kogan 2003 ]. Our results of a 2.2% overall readmission rate also imply that FTRC may offer a postoperative course at least as safe as traditional postoperative care.
The risk factors for readmission have been identifi ed as a longer initial ICU length of stay, poor left ventricle function, a history of congestive heart failure, a longer initial intubation time, renal failure, and prolonged initial mechanical ventilation [Cohn 1999; Bardell 2003] . Prolonged ventilation, which may be associated with a low preoperative ejection fraction, renal failure, chronic obstructive pulmonary disease (COPD), age, sex, and unstable angina, was shown in these studies to be one of the strongest predictors of a return to the ICU; however, this was not the case for FTRC, which usually aims for a limited period of mechanical ventilation. Thus, the previously defi ned relationship of ICU readmission to prolonged ventilation in reality may be associated with an underlying cause, such as a low preoperative ejection fraction, renal failure, COPD, or age.
The primary interesting fi nding of the study is that the risk factors for readmission after cardiac surgery with FTRC may differ according to the type of operation. Defi ning such specifi c operation-related risk factors may be benefi cial for optimizing risk stratifi cation for a patient planned for FTRC. Although the clinical status at the time of readmission was uniform among all of the groups and primarily related to respiratory and rhythm disorders, the risk factors were quite different in the study. Independent risk factors in the CABG group were an age >65 years, peripheral arterial disease, and drainage >500 mL; however, the only independent risk factor defi ned in the valve group was preoperative congestive heart failure. We could not defi ne any independent risk factors for the CABG + valve group. The number of patients in this group was 163, which was quite low for a multivariate analysis of risk factors; however, the leading reason for readmission in this group was also preoperative congestive heart failure, which may be determined to be a risk factor with a larger patient group.
The secondary fi nding of the study indicates that readmission to the ICU after FTRC is associated with a signifi cantly prolonged ICU stay and an increased mortality rate. The ICU stay for readmitted patients was increased approximately 7-fold in the CABG group, 5-fold in the valve group, and 6-fold in the CABG + valve group. Moreover, the mortality rate was higher after readmission, approximately 27-fold in the CABG group, 8-fold in the valve group, and 6-fold in the CABG + valve group. This result implies that defi ning the high-risk group for readmission with perioperative risk factors may allow modifi cation of the postoperative care, thereby preventing an unfavorable outcome.
Previous studies have demonstrated that FTRC is a safe and effective option for patients undergoing cardiac surgery, even for high-risk groups [Marquez 1995; Cheng 1998; Alhan 2003 ]. The primary objective criteria for FTRC are early extubation and early discharge from the ICU and the hospital. Early extubation and early discharge from the ICU and the hospital do not refl ect the real success of FTRC, however. The real criterion for success should be the application of FTRC with acceptable rates of ICU and hospital readmissions. Although observed at a lower incidence compared with traditional postoperative care, readmission after FTRC is still an important indicator of a poor outcome [Kogan 2003 ]. 
